MedPath

Takeda Pharmaceutical Company Ltd

🇯🇵Japan
Ownership
-
Established
1925-01-01
Employees
-
Market Cap
$47.5B
Website
http://www.takeda.co.jp/

Ramelteon in Adults With Chronic Insomnia

Phase 3
Completed
Conditions
Chronic Insomnia
Interventions
Drug: Placebo
First Posted Date
2008-05-05
Last Posted Date
2012-11-20
Lead Sponsor
Takeda
Target Recruit Count
848
Registration Number
NCT00671567

Study of Efficacy of Ramelteon in Adults With Chronic Insomnia

Phase 3
Completed
Conditions
Chronic Insomnia
Interventions
Drug: Placebo
First Posted Date
2008-05-05
Last Posted Date
2012-11-12
Lead Sponsor
Takeda
Target Recruit Count
405
Registration Number
NCT00671125

Safety and Efficacy of Ramelteon in Healthy Subjects

Phase 2
Completed
Conditions
Sleep Disorder
Interventions
Drug: Placebo
First Posted Date
2008-05-05
Last Posted Date
2012-02-28
Lead Sponsor
Takeda
Target Recruit Count
75
Registration Number
NCT00671190

Safety and Efficacy of Ramelteon in Elderly Subjects With Chronic Insomnia

Phase 3
Completed
Conditions
Chronic Insomnia
Interventions
Drug: Placebo
First Posted Date
2008-05-05
Last Posted Date
2012-02-28
Lead Sponsor
Takeda
Target Recruit Count
829
Registration Number
NCT00671255

Behavioral and Subjective Efficacy of Ramelteon in Subjects With a History of Polydrug Abuse

Phase 2
Completed
Conditions
Drug Abuse
Interventions
Drug: Ramelteon, triazolam, and placebo (56 possible combinations total)
First Posted Date
2008-05-05
Last Posted Date
2012-02-28
Lead Sponsor
Takeda
Target Recruit Count
14
Registration Number
NCT00671632

Efficacy of Ramelteon on Transient Insomnia in Healthy Adults

Phase 3
Completed
Conditions
Transient Insomnia
Interventions
Drug: Placebo
First Posted Date
2008-05-05
Last Posted Date
2012-02-28
Lead Sponsor
Takeda
Target Recruit Count
289
Registration Number
NCT00671398

Efficacy of Ramelteon in Subjects With Chronic Insomnia

Phase 3
Completed
Conditions
Sleep Initiation and Maintenance Disorders
Interventions
First Posted Date
2008-05-05
Last Posted Date
2012-02-28
Lead Sponsor
Takeda
Target Recruit Count
1213
Registration Number
NCT00671086

Safety and Efficacy of Ramelteon in Elderly Subjects With Chronic Insomnia.

Phase 3
Completed
Conditions
Chronic Insomnia
Interventions
First Posted Date
2008-05-05
Last Posted Date
2012-02-28
Lead Sponsor
Takeda
Target Recruit Count
100
Registration Number
NCT00671294

Long-Term Efficacy of Ramelteon on Endocrine Function in Adult Subjects With Chronic Insomnia

Phase 3
Completed
Conditions
Insomnia
Interventions
Drug: Placebo
First Posted Date
2008-04-14
Last Posted Date
2012-02-28
Lead Sponsor
Takeda
Target Recruit Count
122
Registration Number
NCT00656994

Efficacy of Alogliptin and With Pioglitazone in Patients With Type 2 Diabetes.

Phase 3
Completed
Conditions
Diabetes Mellitus
Interventions
First Posted Date
2008-04-10
Last Posted Date
2013-05-27
Lead Sponsor
Takeda
Target Recruit Count
71
Registration Number
NCT00655863
© Copyright 2025. All Rights Reserved by MedPath